Analystreport

Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) was upgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "overweight" rating.

Crinetics Pharmaceuticals, Inc.  (CRNX) 
Last crinetics pharmaceuticals, inc. earnings: 3/9 04:10 pm Check Earnings Report